Skip to main content
Earnings Labs
Liminatus Pharma, Inc. Class A Common Stock logo

Liminatus Pharma, Inc. Class A Common Stock (LIMN) Earnings

NASDAQ·Healthcare·Biotechnology

$2.89

-8.54%

Mkt Cap $6.34M

EPS — Estimate vs Actual

Mkt Cap

$6.34M

P/E

—

Fwd P/E

—

P/S

—

Rev TTM

—

EPS TTM

-$2.91